Zobrazeno 1 - 10
of 11
pro vyhledávání: '"M N, Pollak"'
Autor:
O, Kucuk, F H, Sarkar, W, Sakr, Z, Djuric, M N, Pollak, F, Khachik, Y W, Li, M, Banerjee, D, Grignon, J S, Bertram, J D, Crissman, E J, Pontes, D P, Wood
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 10(8)
An inverse association has been observed between dietary intake of lycopene and the risk of prostate cancer. We investigated the effects of lycopene supplementation in patients with prostate cancer. Twenty-six men with newly diagnosed, clinically loc
Publikováno v:
Journal of the American Academy of Dermatology. 42(6)
A recent report suggested that men with vertex balding have higher levels of plasma insulin-like growth factor 1 (IGF-1). The association of its major carrier protein, insulin-like growth factor binding protein 3 (IGFBP-3), with male pattern hair los
Autor:
E, Giovannucci, M N, Pollak, E A, Platz, W C, Willett, M J, Stampfer, N, Majeed, G A, Colditz, F E, Speizer, S E, Hankinson
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 9(4)
Insulin-like growth factor-1 (IGF-1) is an important mitogen, and IGF binding protein-3 (IGFBP-3) has opposing effects. Acromegalics, who have abnormally elevated levels of IGF-1, are at increased risk of colorectal tumors. Recent studies have found
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 8(12)
African-American men have the highest and Asian-American men have the lowest prostate cancer incidence rates in the United States; internationally, rates for the Asian continent are among the lowest. Higher insulin-like growth factor (IGF)-1, which p
Autor:
J N, Ingle, V J, Suman, C G, Kardinal, J E, Krook, J A, Mailliard, M H, Veeder, C L, Loprinzi, R J, Dalton, L C, Hartmann, C A, Conover, M N, Pollak
Publikováno v:
Cancer. 85(6)
Tamoxifen (TAM) is generally considered the hormonal agent of choice for postmenopausal women with hormone receptor positive breast carcinoma. The somatostatin analogues, including octreotide, have demonstrated inhibition of breast carcinoma cell lin
Publikováno v:
Cancer. 80(3)
In the Ashkenazim, three recurrent germline mutations have been identified in the breast carcinoma susceptibility genes BRCA1 and BRCA2: 185delAG, 5382insC (BRCA1), and 6174delT (BRCA2). The frequency of these mutations in the general Ashkenazi popul
Autor:
S E, Pratt, M N, Pollak
Publikováno v:
Cancer research. 53(21)
Many neoplastic cell lines secrete insulin-like growth factor binding proteins (IGFBPs). The physiological role of these proteins is incompletely characterized; under various conditions IGFBPs have been observed to either enhance or inhibit the biolo
Autor:
M. N. Pollak
Publikováno v:
High-Risk Breast Cancer ISBN: 9783642747304
Despite recent advances, current therapies for metastatic breast cancer rarely achieve response rates greater than 60%, and complete responses are rare. Adjuvant treatment of certain stage I and II breast cancer patients can improve survival compared
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18de2c7d951d6dea0199d01f8e3c92a6
https://doi.org/10.1007/978-3-642-74728-1_26
https://doi.org/10.1007/978-3-642-74728-1_26
Autor:
R N, Buick, M N, Pollak
Publikováno v:
Cancer research. 44(11)
Autor:
M N, Pollak
Publikováno v:
Computer programs in biomedicine. 16(3)
Clinical trials involve the administration of new or experimental treatments to patients and the subsequent observation of responses to these treatments over appropriate periods of time. During a clinical trial, large volumes of data describing the c